Advertisement
News
Advertisement

Covidien device joins stroke treatment trial

Mon, 01/30/2012 - 9:36am
Mass High Tech: The Journal of New England Technology

The Solitaire FR Revascularization Device by Covidien plc won approval for investigational use in the thromectomy part of the Interventional Management of Stroke (IMS III) trial, funded by the National Institute of Neurological Disorders and Stroke.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading